Daniel Deykin
- Internal Medicine top 0.1%
- Venous Thromboembolism Diagnosis and Management 25
- Hematology top 0.2%
- Platelet Disorders and Treatments 18
-
- Antiplatelet Therapy and Cardiovascular Diseases 30
- Atrial Fibrillation Management and Outcomes 19
- Biochemistry top 0.2%
- Eicosanoids and Hypertension Pharmacology 22
- Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects 14
-
- Heparin-Induced Thrombocytopenia and Thrombosis 14
-
- Peroxisome Proliferator-Activated Receptors 14
- Co-authors
- James E. DalenL. PollerJack AnsellJack HirshHenry I. BusseyRuth M. KramerSusan Rittenhouse-SimmonsDavid R. Anderson
- Journals
- New England Journal of Medicine (25 papers)Journal of Clinical Investigation (10 papers)Journal of Biological Chemistry (10 papers)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Daniel Deykin
157 papers receiving 10.9k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Internal Medicine 2.5k
- Hematology 2.3k
- Cardiology and Cardiovascular Medicine 4.0k
- Biochemistry 1.0k
- Pharmacology 675
Countries citing papers authored by Daniel Deykin
This map shows the geographic impact of Daniel Deykin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Deykin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Deykin more than expected).
Fields of papers citing papers by Daniel Deykin
This network shows the impact of papers produced by Daniel Deykin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Deykin. The network helps show where Daniel Deykin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel Deykin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 446 | |
| 2 | Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Rangebreakdown → | 2001 | 1184 |
| 3 | 1998 | 9 | |
| 4 | 1996 | 8 | |
| 5 | Discussion: Frank W Rockhold and G Enas, data monitoring and interim analyses in the pharmaceutical industry: Ethical and logistical considerations: George W Williams et al, monitoring of clinical trials and interim analyses from a drug sponsor's point of view | 1993 | 1 |
| 6 | 1993 | 4 | |
| 7 | Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillationbreakdown → | 1992 | 850 |
| 8 | 1991 | 19 | |
| 9 | 1991 | 11 | |
| 10 | 1990 | 6 | |
| 11 | 1990 | 298 | |
| 12 | 1988 | 40 | |
| 13 | 1988 | 69 | |
| 14 | 1988 | 21 | |
| 15 | 1987 | 2 | |
| 16 | 1987 | 37 | |
| 17 | 1985 | 83 | |
| 18 | 1976 | 28 | |
| 19 | 1969 | 29 | |
| 20 | 1964 | 8 |
About Daniel Deykin
Daniel Deykin is a scholar working on Internal Medicine, Biochemistry and Hematology, having authored 157 papers that have together received 11.8k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (30 papers), Venous Thromboembolism Diagnosis and Management (25 papers), Eicosanoids and Hypertension Pharmacology (22 papers), Atrial Fibrillation Management and Outcomes (19 papers), Platelet Disorders and Treatments (18 papers), Inflammatory mediators and NSAID effects (14 papers), Heparin-Induced Thrombocytopenia and Thrombosis (14 papers) and Peroxisome Proliferator-Activated Receptors (14 papers). The work is most often cited by research in Internal Medicine (2.5k citations), Hematology (2.3k citations) and Cardiology and Cardiovascular Medicine (4.0k citations). Daniel Deykin has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include James E. Dalen, L. Poller, Jack Ansell, Jack Hirsh, Henry I. Bussey, Ruth M. Kramer, Susan Rittenhouse-Simmons, David R. Anderson, Christine Balko and S L Hong. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Investigation, Journal of Biological Chemistry, CHEST Journal and Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.